|
2022 Journal Article In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case seriesSanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H. Peter and Schaider, Helmut (2022). In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case series. Cancers, 14 (11) 2801, 2801. doi: 10.3390/cancers14112801 |
|
2022 Journal Article Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trialChong, Sharene, Wong, Ho Yi, Althabteh, Ahmad, Cox, Charlotte, Stevenson, Paul H., Brown, Susan, Griffin, Anthony, Isbel, Nicole, Siller, Gregory, Soyer, H. Peter, Schaider, Helmut, Roy, Edwige, Campbell, Scott, Green, Adele C. and Khosrotehrani, Kiarash (2022). Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial. Journal of the American Academy of Dermatology, 87 (5), 1163-1166. doi: 10.1016/j.jaad.2022.02.039 |
|
2022 Journal Article Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort studyHorsham, Caitlin, O'Hara, Montana, Sanjida, Saira, Ma, Samantha, Jayasinghe, Dilki, Green, Adele C, Schaider, Helmut, Aitken, Joanne F, Sturm, Richard A, Prow, Tarl, Soyer, H. Peter and Janda, Monika (2022). Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort study. JMIR Dermatology, 5 (2) e37034, e37034. doi: 10.2196/37034 |
|
2021 Conference Publication Preclinical study of aspirin and regorafenib combination therapy for colorectal cancerSu, C., Bond, C., Fennell, L., Kerr, G., Jarde, T., Micati, D., Engel, R., Chan, W. H., Hlavca, S., Archer, S., Mcmurrick, P., Hammerlindl, H., Lim, F., Salik, B., Mckeone, D., Hartel, G., Leggett, B., Schaider, H., Abud, H., Boyle, G., Burge, M. and Whitehall, V. (2021). Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer. GESA AGW 2021, Online, 4 - 12 September 2021. HOBOKEN: WILEY. |
|
2021 Journal Article An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomasWang, Jing, Kao, Yung‐Ching, Zhou, Quan, Wuethrich, Alain, Stark, Mitchell S., Schaider, Helmut, Soyer, H. Peter, Lin, Lynlee L. and Trau, Matt (2021). An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomas. Advanced Functional Materials, 32 (3) 2010296, 1-9. doi: 10.1002/adfm.202010296 |
|
2020 Journal Article Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variantsRayner, Jenna E., Duffy, David L., Smit, Darren J., Jagirdar, Kasturee, Lee, Katie J., De’Ambrosis, Brian, Smithers, B. Mark, McMeniman, Erin K., McInerney-Leo, Aideen M., Schaider, Helmut, Stark, Mitchell S., Soyer, H. Peter and Sturm, Richard A. (2020). Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants. PLoS ONE, 15 (9) e0238529, e0238529. doi: 10.1371/journal.pone.0238529 |
|
2020 Journal Article Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controlsDuffy, David L., Jagirdar, Kasturee, Lee, Katie J., McWhirter, Seamus R., McMeniman, Erin K., De’Ambrosis, Brian, Pflugfelder, Annette, Rayner, Jenna E., Whiteman, David C., Brown, Matthew A., Martin, N.G., Smithers, B.M., Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2020). Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls. Journal of Investigative Dermatology, 140 (2), 498-501.e17. doi: 10.1016/j.jid.2019.05.032 |
|
2020 Journal Article Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancerMenon, Dinoop Ravindran, Hammerlindl, Heinz, Torrano, Joachim, Schaider, Helmut and Fujita, Mayumi (2020). Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics, 10 (14), 6261-6277. doi: 10.7150/thno.42523 |
|
2019 Journal Article Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, Peter H. and Smithers, Mark B. (2019). Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”. Journal of Surgical Oncology, 120 (6), 1058-1059. doi: 10.1002/jso.25686 |
|
2019 Journal Article Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancerAl Emran, Abdullah, Marzese, Diego M., Menon, Dinoop R., Hammerlindl, Heinz, Ahmed, Farzana, Richtig, Erika, Duijf, Pascal, Hoon, Dave S. B. and Schaider, Helmut (2019). Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics, 11 (7), 723-737. doi: 10.2217/epi-2018-0173 |
|
2019 Journal Article Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterizationHeitzer, Ellen, Groenewoud, Arwin, Meditz, Katharina, Lohberger, Birgit, Liegl-Atzwanger, Bernadette, Prokesch, Andreas, Kashofer, Karl, Behrens, Diana, Haybaeck, Johannes, Kolb-Lenz, Dagmar, Koefeler, Harald, Riedl, Sabrina, Schaider, Helmut, Fischer, Carina, Snaar-Jagalska, B. Ewa, de’Jong, Danielle, Szuhai, Karoly, Zweytick, Dagmar and Rinner, Beate (2019). Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Scientific Reports, 9 (1) 4096, 4096. doi: 10.1038/s41598-019-40570-1 |
|
2019 Journal Article Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogrammingTorrano, Joachim, Al Emran, Abdullah, Hammerlindl, Heinz and Schaider, Helmut (2019). Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. Clinical Epigenetics, 11 (1) 43, 43. doi: 10.1186/s13148-019-0644-y |
|
2019 Journal Article Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanomaEmran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma. Cancer Medicine, 8 (3), 1186-1196. doi: 10.1002/cam4.1978 |
|
2019 Journal Article Cover imageEmran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Cover image. Cancer Medicine, 8 (3), i-i. doi: 10.1002/cam4.2129 |
|
2019 Journal Article A systematic review and meta-analysis of locoregional treatments for in-transit melanomaRead, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2019). A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. Journal of Surgical Oncology, 119 (7) jso.25686, 887-896. doi: 10.1002/jso.25400 |
|
2019 Journal Article The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive reviewDeen, Jacqueline and Schaider, Helmut (2019). The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review. Australasian Journal of Dermatology, 60 (3), e186-e194. doi: 10.1111/ajd.12992 |
|
2019 Conference Publication Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanomaSpoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Smith, A., Scott, E., Schaider, H., Gabrielli, B., Weninger, W. and Haass, N. (2019). Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.13859 |
|
2019 Conference Publication ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care settingEconomides, A., Mar, V., Soyer, H. P., Schaider, H., Sadeghi, M. and Guitera, P. (2019). ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting. 2019 Dermcoll, Melbourne, Australia, 18 – 21 May 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2019 Conference Publication Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanomaFaleiro, Rebecca J., Karunarathne, Deshapriya S., Liu, Ji, Boyle, Glen, Hartel, Gunter, Hayward, Nick, Schaider, Helmut, Waddell, Nic, Schmidt, Chris and Wykes, Michelle (2019). Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Atlanta, GA, United States, 29 March - 3 April, 2019. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-4112 |
|
2018 Journal Article Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanomaLaino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter and Schaider, Helmut (2018). Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma. JAAD Case Reports, 4 (9), 921-923. doi: 10.1016/j.jdcr.2018.06.024 |
